Skip to content
i2E
  • Programs
    • For Startups
      • E3
      • Bridge2
      • OCN
    • For Students
      • Entrepreneur’s Cup
    • For Corporations
    • For Investors
  • Client Portfolio
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Events
  • Contact
  • Media
  • Programs
    • For Startups
      • E3
      • Bridge2
      • OCN
    • For Students
      • Entrepreneur’s Cup
    • For Corporations
    • For Investors
  • Client Portfolio
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Events
  • Contact
  • Media
Search

Q&A with Stephen Prescott

Get in Touch

Copyright © 2014, The Oklahoma Publishing Company

Innovations in 2015 brought promise, hope for some patients

Q: What innovation made the biggest impact last year?

Dr. Stephen Prescott
Dr. Stephen Prescott, OMRF

A: Hepatitis C drugs. Led by Gilead’s Sovaldi, which shattered the record for first-year sales of any drug in history, these novel therapeutics are transforming the treatment landscape for the viral liver disease. They’re easy to take, carry few side effects, and deliver cure rates of 90 percent and above. In essence, they could wipe out a disease that affects an estimated 3 million Americans, including 30,000 Oklahomans. The only catch: price tags of nearly $100,000.

Q: Were there any big developments in cancer?

A: In clinical trials, a new class of drugs known as immunotherapeutics were shown to be effective in using the body’s own immune system to destroy cancer cells. Although the trials have been small, the treatments have worked extremely well in patients with advanced melanoma, a deadly skin cancer. Researchers believe these results, which extended patients’ lives by years, could hold true in many other forms of cancer.

Q: How about Alzheimer’s?

A: The news was mixed here. In the first large-scale trial of a treatment aimed at stopping Alzheimer’s in its early stages, an experimental drug failed to make headway. But in December, drugmaker Biogen Idec announced promising results for another novel Alzheimer’s treatment; the company now plans a larger test in patients who show mild symptoms or markers of the disease.

Q: What can we expect in 2015?

A: Biotechnology and pharmaceutical development is focused on two areas right now. The first is personalized therapies, mostly targeting specific types of cancer. This is a field we’re working on at the Oklahoma Medical Research Foundation, in conjunction with the Stephenson Cancer Center. The second major focus for biopharma is drugs for so-called orphan diseases, which affect very small numbers of patients. In 2015, expect to see a variety of new treatments in both of these classes.

— Paula Burkes, Oklahoman Business writer

 

 

More News

Loading...
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.25.25

Oklahoma Collegiate Entrepreneurs Take Home Over $167K at Entrepreneur’s Cup

Read more
Blog, Featured, News
12.16.24

MidAmerica and i2E Announce Award Winners

Read more
Blog, Featured, News
11.21.24

i2E & Plains Ventures Surpasses $100M Milestone in Total Investments

Read more
Blog
09.30.24

i2E Receives 2024 Excellence in Economic Development Award from IEDC

Read more
Blog
06.18.24

Bridge2 Demo Day Returns, Highlighting Promising Oklahoma Startups

Read more
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
05.13.24

Student Entrepreneurs Triumph at 20th Anniversary Entrepreneur’s Cup, Winning $158,000 in Prizes

Read more
Default Featured Image
Blog, Entrepreneur's Cup News
04.24.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Jessica Kinsey

Read more
Default Featured Image
Blog, Entrepreneur's Cup News
04.23.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Nathan Fountain

Read more
Default Featured Image
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.23.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Srijita Ghosh

Read more
Default Featured Image
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.18.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – MaxQ

Read more
Blog, i2E
01.30.24

i2E Celebrates Success of Inaugural Bridge2 Demo Day

Read more
Blog, i2E, News
12.18.23

i2E and MidAmerica Industrial Park announce award winners for high school entrepreneurship program

Read more
i2E

Oklahoma City Office

201 Robert S Kerr Ave, Suite 600
Oklahoma City, OK 73102
+1 (405) 235.2305

Tulsa Office

12 N. Cheyenne Ave, Suite 112
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources
  • Funding
  • Venture Advisory

© 2025 i2E Privacy Policy

Follow us:

Linkedin Twitter Facebook Instagram Youtube

Programs

  • For Startups
    • E3
    • Bridge2
    • OCN
  • For Students
    • Entrepreneur’s Cup
  • For Corporations
  • For Investors
  • For Startups
    • E3
    • Bridge2
    • OCN
  • For Students
    • Entrepreneur’s Cup
  • For Corporations
  • For Investors
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Events
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E